Table 1.
Characteristics | Low hs-CRP/PAB group | High hs-CRP/PAB group | P value |
---|---|---|---|
n = 329 | n = 330 | ||
Age (year) | 65.16 ± 10.37 | 67.80 ± 11.77 | 0.002 |
Male gender, n (%) | 191 (58.1) | 169 (51.2) | 0.078 |
Current smoker, n (%) | 89 (27.05) | 100 (30.30) | 0.356 |
Hypertension, n (%) | 196 (59.57) | 217 (65.76) | 0.101 |
Diabetes mellitus, n (%) | 78 (23.71) | 102 (30.90) | 0.038 |
Previous CAD, n (%) | 36 (10.94) | 59 (17.88) | 0.011 |
Killip class II-IV, n (%) | 18 (5.47) | 31 (9.39) | 0.055 |
Heart rate (bpm) | 72 (14.00) | 76 (22.25) | <0.001 |
Laboratory measurement | |||
Hemoglobin (g/dL) | 13.60 ± 1.64 | 12.82 ± 1.77 | <0.001 |
Platelet (×103/μL) | 224.63 ± 55.63 | 226.02 ± 70.17 | 0.778 |
Leukocyte (×103/μL) | 6.21 (1.91) | 7.01 (3.35) | <0.001 |
Glucose (mg/dL) | 95.84 (26.93) | 108.18 (49.14) | <0.001 |
eGFR (mL/min/1.73 m2) | 84.48 ± 27.60 | 82.40 ± 32.44 | 0.010 |
PAB (mg/dL) | 19.84 ± 3.64 | 15.73 ± 4.39 | <0.001 |
Hs-CRP/PAB ratio | 0.004 (0.003) | 0.054 (0.101) | <0.001 |
GOT (u/L) | 21.00 (10.00) | 24.00 (20.00) | <0.001 |
GPT (u/L) | 19.00 (13.00) | 21.00 (19.00) | 0.010 |
LDL-cholesterol (mg/dL) | 101.87 ± 34.75 | 101.92 ± 32.69 | 0.984 |
Hs-CRP (mg/dL) | 0.08 (0.06) | 0.78 (1.40) | <0.001 |
Angiography, n (%) | 169 (51.37) | 164 (49.70) | 0.668 |
1 vessel disease | 110 (33.43) | 85 (25.76) | |
2 vessel diseases | 49 (14.89) | 45 (13.64) | |
3 vessel diseases | 10 (3.04) | 34 (10.30) | <0.001 |
Treatment, n (%) | |||
Primary PCI | 12 (3.65) | 17 (5.15) | 0.347 |
LMWH | 100 (30.40) | 116 (35.15) | 0.193 |
Anti-platelet | 321 (97.57) | 323 (97.88) | 0.789 |
Beta-blocker | 207 (62.92) | 195 (59.09) | 0.191 |
ACEI/ARB | 140 (42.55) | 169 (51.21) | 0.026 |
Statin | 156 (47.42) | 148 (44.85) | 0.508 |
Abbreviation: Hs-CRP: high sensitivity C-reactive protein; PAB: prealbumin; CAD: coronary artery disease; eGFR: estimated glomerular filtration rate; GOT: glutamate oxaloacetate transaminase; GPT: glutamate pyruvate transaminase; LDL: low density lipoproteins; PCI: percutaneous coronary intervention; LMWH: low molecular weight heparin; ACEI: angiotensin-converting-enzyme inhibitor; ARB: angiotensin receptor blockers.